Age and duration of follow-up as modulators of the risk for ischemic heart disease associated with high plasma C-reactive protein levels in men

Archives of Internal Medicine

Volumn 161, Issue 20, 2001, Pages 2474-2480

  Pirro, Matteo ^a   Bergeron, Jean ^a   Dagenais, Gilles R ^b   Bernard, Paul Marie ^c   Cantin, Bernard ^a,b   Després, Jean Pierre ^a,b   Lamarche, Benoît ^a  

^a LAVAL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; LIPID;

ADULT; AGE; ARTICLE; CANADA; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 0035851294     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.20.2474     Document Type: Article

References (26)

1. Inflammation in cardiovascular disease: Cart, horse, or both?
2. Prospective studies of C-reactive protein as a risk factor for cardiovascular disease
3. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
4. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
5. Production of C-reactive protein and risk of coronary events in stable and unstable angina: European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
6. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events (CARE) Investigators
7. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction
8. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
9. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992
10. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly
11. First coronary heart disease event rates in relation to major risk factors: Québec Cardiovascular Study
12. Prevalence of dyslipidemic pheno-types in ischemic heart disease (prospective results from the Québec Cardiovascular Study)
13. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma
14. Multi-laboratory comparison of three heparin-MnC12 precipitation procedures for estimating cholesterol in high-density lipoproteins
15. Estimation of the concentration of Iow-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
16. Electroimmunoassay
17. C-reactive protein fifty years on
18. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
19. NIDDM as a disease ofthe innate immune system: Association of acute-phase reactants and interleukin -6 with metabolic syndrome X
20. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial
21. Elevated C-reactive protein levels in overweight and obese adults
22. Reduction of the plasma concentration of C-reactive protein following nine months of endurance training
23. Long-term effects of pravastatin on plasma concentration of C-reactive protein: The Cholesterol and Recurrent Events (CARE) Investigators
24. Heat production of atherosclerotic plaques and inflammation assessed bythe acute phase proteins in acute coronary syndromes
25. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study
26. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty